North America Penicillin Drug Market Size, Share & Industry Trends Analysis Report By Source, By Spectrum of Activity, By Distribution Channel, By Route of Administration, By Country and Growth Forecast, 2023

List of Tables

The North America Penicillin Drug Market would witness market growth of 2.7% CAGR during the forecast period (2023-2030).

Skin infections, tooth infections, ear infections, nose, throat, or lungs infections, urinary tract infections, and other bacterial diseases are all common health concerns worldwide. The bacteria Streptococcus pneumonia, Listeria, Neisseria gonorrhea, Clostridium, Peptococcus, and Peptostreptococcus belong to the organisms that penicillin is effective against.

The enormous prevalence of pneumonia and other respiratory tract illnesses is a factor in the market's expansion. Since penicillin is an established and reliable antibiotic, it continues to be the first line of treatment for many bacterial illnesses. The increasing prevalence of these illnesses in both public and medical settings necessitate the use of penicillin and fuels the expansion of the market.

Additionally, improvements in healthcare infrastructure and accessibility to healthcare services greatly impact the market share. The identification and treatment of bacterial infections have improved due to improving healthcare infrastructure, particularly in developing nations. The availability and accessibility of penicillin are improved as healthcare systems grow, resulting in higher consumption and market expansion.

The American Cancer Society reports that in 2018, there were roughly 154,050 lung cancer-related deaths in the United States, with an estimated 234,030 new cases of lung cancer being diagnosed. 541,000 Americans have been given a lung cancer diagnosis at some point in their lives, according to the American Lung Association. Many patients have received a lung cancer diagnosis during the last five years. Each year, non-small cell lung cancer (NSCLC) is treated in tens of thousands of Americans. Additionally, chronic diseases are becoming more common in the region. Because of the increase in cancer incidence, there is a greater need for products such as penicillin drugs, which boosts the regional market.

The US market dominated the North America Penicillin Drug Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2.1 billion by 2030. The Canada market is poised to grow at a CAGR of 5% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 4.1% during (2023 - 2030).

Based on Source, the market is segmented into Semisynthetic Penicillin and Natural Penicillin. Based on Spectrum of Activity, the market is segmented into Broad spectrum, Extended spectrum and Narrow spectrum. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Route of Administration, the market is segmented into Parenteral and Oral. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Novartis AG, Lupin Limited, Abbott Laboratories, Cipla Limited, Takeda Pharmaceutical Company Limited, Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd.

Scope of the Study

Market Segments covered in the Report:

By Source

Semisynthetic Penicillin
Natural Penicillin

By Spectrum of Activity

Broad spectrum
Extended spectrum
Narrow spectrum

By Distribution Channel

Drug Stores & Retail Pharmacies
Hospital Pharmacies
Online Providers

By Route of Administration

Parenteral
Oral

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

GlaxoSmithKline PLC (GSK)
Pfizer, Inc.
Novartis AG
Lupin Limited
Abbott Laboratories
Cipla Limited
Takeda Pharmaceutical Company Limited
Alkem Laboratories Ltd.
Teva Pharmaceuticals Industries Ltd.
Sun Pharmaceutical Industries Ltd.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Penicillin Drug Market, by Source
- 1.4.2 North America Penicillin Drug Market, by Spectrum of Activity
- 1.4.3 North America Penicillin Drug Market, by Distribution Channel
- 1.4.4 North America Penicillin Drug Market, by Route of Administration
- 1.4.5 North America Penicillin Drug Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Trials and Approvals
4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun - 2023, Mar) Leading Players
4.4 Porter Five Forces Analysis

Chapter 5. North America Penicillin Drug Market by Source

5.1 North America Semisynthetic Penicillin Market by Country
5.2 North America Natural Penicillin Market by Country

Chapter 6. North America Penicillin Drug Market by Spectrum of Activity

6.1 North America Broad spectrum Market by Country
6.2 North America Extended spectrum Market by Country
6.3 North America Narrow spectrum Market by Country

Chapter 7. North America Penicillin Drug Market by Distribution Channel

7.1 North America Drug Stores & Retail Pharmacies Market by Country
7.2 North America Hospital Pharmacies Market by Country
7.3 North America Online Providers Market by Country

Chapter 8. North America Penicillin Drug Market by Route of Administration

8.1 North America Parenteral Market by Country
8.2 North America Oral Market by Country

Chapter 9. North America Penicillin Drug Market by Country

9.1 US Penicillin Drug Market
- 9.1.1 US Penicillin Drug Market by Source
- 9.1.2 US Penicillin Drug Market by Spectrum of Activity
- 9.1.3 US Penicillin Drug Market by Distribution Channel
- 9.1.4 US Penicillin Drug Market by Route of Administration
9.2 Canada Penicillin Drug Market
- 9.2.1 Canada Penicillin Drug Market by Source
- 9.2.2 Canada Penicillin Drug Market by Spectrum of Activity
- 9.2.3 Canada Penicillin Drug Market by Distribution Channel
- 9.2.4 Canada Penicillin Drug Market by Route of Administration
9.3 Mexico Penicillin Drug Market
- 9.3.1 Mexico Penicillin Drug Market by Source
- 9.3.2 Mexico Penicillin Drug Market by Spectrum of Activity
- 9.3.3 Mexico Penicillin Drug Market by Distribution Channel
- 9.3.4 Mexico Penicillin Drug Market by Route of Administration
9.4 Rest of North America Penicillin Drug Market
- 9.4.1 Rest of North America Penicillin Drug Market by Source
- 9.4.2 Rest of North America Penicillin Drug Market by Spectrum of Activity
- 9.4.3 Rest of North America Penicillin Drug Market by Distribution Channel
- 9.4.4 Rest of North America Penicillin Drug Market by Route of Administration

Chapter 10. Company Profiles

10.1 Novartis AG
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expense
- 10.1.5 Recent strategies and developments:
  - 10.1.5.1 Partnerships, Collaborations, and Agreements:
  - 10.1.5.2 Acquisition and Mergers:
- 10.1.6 SWOT Analysis
10.2 Teva Pharmaceutical Industries Ltd.
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Regional Analysis
- 10.2.4 Research & Development Expenses
- 10.2.5 SWOT Analysis
10.3 Sun Pharmaceutical Industries Ltd.
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Regional Analysis
- 10.3.4 Research & Development Expenses
- 10.3.5 Recent strategies and developments:
  - 10.3.5.1 Acquisition and Mergers:
- 10.3.6 SWOT Analysis
10.4 GlaxoSmithKline PLC (GSK)
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 Recent strategies and developments:
  - 10.4.5.1 Partnerships, Collaborations, and Agreements:
- 10.4.6 SWOT Analysis
10.5 Pfizer, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Regional & Segmental Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 Recent strategies and developments:
  - 10.5.5.1 Partnerships, Collaborations, and Agreements:
  - 10.5.5.2 Acquisition and Mergers:
  - 10.5.5.3 Trials and Approvals:
- 10.5.6 SWOT Analysis
10.6 Lupin Limited
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Recent strategies and developments:
  - 10.6.3.1 Partnerships, Collaborations, and Agreements:
- 10.6.4 SWOT Analysis
10.7 Abbott Laboratories
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expense
- 10.7.5 SWOT Analysis
10.8 Cipla Limited
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Regional Analysis
- 10.8.4 Research & Development Expense
- 10.8.5 Recent strategies and developments:
  - 10.8.5.1 Partnerships, Collaborations, and Agreements:
  - 10.8.5.2 Acquisition and Mergers:
- 10.8.6 SWOT Analysis
10.9 Alkem Laboratories Ltd.
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Regional Analysis
- 10.9.4 Research & Development Expenses
- 10.9.5 Recent strategies and developments:
  - 10.9.5.1 Product Launches and Product Expansions:
- 10.9.6 SWOT Analysis
10.10. Takeda Pharmaceutical Company Limited
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 Regional Analysis
- 10.10.4 Research & Development Expense
- 10.10.5 Recent strategies and developments:
  - 10.10.5.1 Acquisition and Mergers:
- 10.10.6 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 2 North America Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Penicillin Drug Market
TABLE 4 Product Launches And Product Expansions- Penicillin Drug Market
TABLE 5 Acquisition and Mergers- Penicillin Drug Market
TABLE 6 Trials and Approvals- Penicillin Drug Market
TABLE 7 North America Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 8 North America Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 9 North America Semisynthetic Penicillin Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Semisynthetic Penicillin Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Natural Penicillin Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Natural Penicillin Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 14 North America Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 15 North America Broad spectrum Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Broad spectrum Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Extended spectrum Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Extended spectrum Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Narrow spectrum Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Narrow spectrum Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 North America Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 23 North America Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 30 North America Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 31 North America Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Parenteral Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Oral Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Penicillin Drug Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Penicillin Drug Market by Country, 2023 - 2030, USD Million
TABLE 37 US Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 38 US Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 39 US Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 40 US Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 41 US Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 42 US Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 43 US Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 44 US Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 45 US Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 46 US Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 47 Canada Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 48 Canada Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 49 Canada Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 50 Canada Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 51 Canada Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 52 Canada Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 53 Canada Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 Canada Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 55 Canada Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Canada Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 57 Mexico Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 58 Mexico Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 59 Mexico Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 60 Mexico Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 61 Mexico Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 62 Mexico Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 63 Mexico Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 Mexico Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 65 Mexico Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 66 Mexico Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 67 Rest of North America Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 68 Rest of North America Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 69 Rest of North America Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 70 Rest of North America Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 71 Rest of North America Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 72 Rest of North America Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 73 Rest of North America Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Rest of North America Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 75 Rest of North America Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 76 Rest of North America Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 77 Key Information - Novartis AG
TABLE 78 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 79 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 80 Key Information - GlaxoSmithKline PLC
TABLE 81 Key Information - Pfizer, Inc.
TABLE 82 Key Information - Lupin Limited
TABLE 83 Key Information - Abbott Laboratories
TABLE 84 Key Information - Cipla Limited
TABLE 85 Key Information - Alkem Laboratories Ltd.
TABLE 86 Key Information - Takeda Pharmaceutical Company Limited

List of Figures

FIG 1 Methodology for the research
FIG 2 North America Penicillin Drug Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Penicillin Drug Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun - 2023, Mar) Leading Players
FIG 7 Porter's Five Forces Analysis - Penicillin Drug Market
FIG 8 North America Penicillin Drug Market share by Source, 2022
FIG 9 North America Penicillin Drug Market share by Source, 2030
FIG 10 North America Penicillin Drug Market by Source, 2019 - 2030, USD Million
FIG 11 North America Penicillin Drug Market share by Spectrum of Activity, 2022
FIG 12 North America Penicillin Drug Market share by Spectrum of Activity, 2030
FIG 13 North America Penicillin Drug Market by Spectrum of Activity, 2019 - 2030, USD Million
FIG 14 North America Penicillin Drug Market share by Distribution Channel, 2022
FIG 15 North America Penicillin Drug Market share by Distribution Channel, 2030
FIG 16 North America Penicillin Drug Market by Distribution Channel, 2019 - 2030, USD Million
FIG 17 North America Penicillin Drug Market share by Route of Administration, 2022
FIG 18 North America Penicillin Drug Market share by Route of Administration, 2030
FIG 19 North America Penicillin Drug Market by Route of Administration, 2019 - 2030, USD Million
FIG 20 North America Penicillin Drug Market share by Country, 2022
FIG 21 North America Penicillin Drug Market share by Country, 2030
FIG 22 North America Penicillin Drug Market by Country, 2019 - 2030, USD Million
FIG 23 SWOT Analysis: Novartis AG
FIG 24 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 25 SWOT Analysis: Sun Pharmaceutical Industries Ltd.
FIG 26 SWOT Analysis: GlaxoSmithKline PLC
FIG 27 Recent strategies and developments: Pfizer, Inc.
FIG 28 SWOT Analysis: Pfizer, Inc.
FIG 29 SWOT Analysis: Lupin Limited
FIG 30 SWOT Analysis: Abbott Laboratories
FIG 31 SWOT Analysis: Cipla Limited
FIG 32 SWOT Analysis: Alkem Laboratories Ltd.
FIG 33 SWOT Analysis: Takeda Pharmaceutical Company Limited

North America Penicillin Drug Market Size, Share & Industry Trends Analysis Report By Source, By Spectrum of Activity, By Distribution Channel, By Route of Administration, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents